tiprankstipranks
Trending News
More News >
Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
US Market
Advertisement

Cyclacel Pharmaceuticals (CYCC) Ratios

Compare
795 Followers

Cyclacel Pharmaceuticals Ratios

CYCC's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, CYCC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.77 0.91 3.30 7.73 14.27
Quick Ratio
5.77 0.91 4.07 7.62 13.99
Cash Ratio
5.63 0.41 2.48 6.91 13.44
Solvency Ratio
-8.32K -2.75 -1.77 -3.54 -2.38
Operating Cash Flow Ratio
-5.83K -1.97 -2.82 -3.50 -3.19
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 3.61K$ -754.00K$ 12.42M$ 35.62M$ 31.93M
Leverage Ratios
Debt-to-Assets Ratio
2.27 <0.01 <0.01 <0.01 0.03
Debt-to-Equity Ratio
2.75 0.06 <0.01 <0.01 0.03
Debt-to-Capital Ratio
0.73 0.06 <0.01 <0.01 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.21 14.51 1.77 1.14 1.11
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.02 0.16 0.05 4.36
Net Debt to EBITDA
>-0.01 0.13 0.66 1.61 3.05
Profitability Margins
Gross Profit Margin
120.00%100.00%0.00%0.00%0.00%
EBIT Margin
41660.00%-6060.24%0.00%0.00%0.00%
EBITDA Margin
41648.00%-6052.86%0.00%0.00%0.00%
Operating Profit Margin
41432.00%-6060.24%0.00%0.00%0.00%
Pretax Profit Margin
21688.00%-6083.57%0.00%0.00%0.00%
Net Profit Margin
25632.00%-5370.24%0.00%0.00%0.00%
Continuous Operations Profit Margin
25632.00%-5370.24%0.00%0.00%0.00%
Net Income Per EBT
118.19%88.27%81.80%83.08%87.23%
EBT Per EBIT
52.35%100.39%93.70%99.11%91.02%
Return on Assets (ROA)
-145603.27%-256.16%-77.08%-44.35%-22.95%
Return on Equity (ROE)
32706.81%-3715.82%-136.68%-50.69%-25.39%
Return on Capital Employed (ROCE)
-284482.29%-3952.33%-137.53%-61.51%-30.99%
Return on Invested Capital (ROIC)
-336215.88%-3488.90%-112.50%-51.10%-27.04%
Return on Tangible Assets
-145603.27%-256.16%-77.08%-44.35%-22.95%
Earnings Yield
-50.57%-31.03%-322.19%-54.39%-29.76%
Efficiency Ratios
Receivables Turnover
-0.50 0.14 0.00 0.00 0.00
Payables Turnover
0.03 0.00 0.01 0.02 0.04
Inventory Turnover
0.00 0.00 >-0.01 0.07 0.03
Fixed Asset Turnover
-1.39K 4.12 0.00 0.00 0.00
Asset Turnover
-5.68 0.05 0.00 0.00 0.00
Working Capital Turnover Ratio
-0.02 0.05 0.00 0.00 0.00
Cash Conversion Cycle
-14.17K 2.55K -93.54K -13.07K 3.10K
Days of Sales Outstanding
-730.00 2.55K 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 -64.33K 4.90K 12.48K
Days of Payables Outstanding
13.44K 0.00 29.21K 17.97K 9.38K
Operating Cycle
-730.00 2.55K -64.33K 4.90K 12.48K
Cash Flow Ratios
Operating Cash Flow Per Share
-2.80 -9.47 -31.67 -31.16 -32.75
Free Cash Flow Per Share
-2.80 -9.47 -31.68 -31.20 -33.15
CapEx Per Share
0.00 <0.01 0.01 0.05 0.40
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-107.98K -77.84 -100.13 -81.32 -26.71
Capital Expenditure Coverage Ratio
0.00 -2.69K -2.98K -686.67 -82.65
Operating Cash Flow Coverage Ratio
-442.73 -435.46 -196.48 -618.00 -7.51
Operating Cash Flow to Sales Ratio
177.09 -38.36 0.00 0.00 0.00
Free Cash Flow Yield
-34.84%-22.17%-316.65%-53.47%-28.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.98 -3.22 -0.31 -1.84 -3.36
Price-to-Sales (P/S) Ratio
-508.27 173.08 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
3.49K 119.76 0.42 0.93 0.85
Price-to-Free Cash Flow (P/FCF) Ratio
-2.87 -4.51 -0.32 -1.87 -3.53
Price-to-Operating Cash Flow Ratio
-2.86 -4.51 -0.32 -1.87 -3.58
Price-to-Earnings Growth (PEG) Ratio
-0.17 0.52 -0.20 0.21 0.04
Price-to-Fair Value
3.49K 119.76 0.42 0.93 0.85
Enterprise Value Multiple
-1.22 -2.73 0.42 0.08 0.37
Enterprise Value
12.71M 69.35M -11.66M -1.81M -3.97M
EV to EBITDA
-1.22 -2.73 0.42 0.08 0.37
EV to Sales
-508.50 165.13 0.00 0.00 0.00
EV to Free Cash Flow
-2.87 -4.30 0.56 0.10 0.49
EV to Operating Cash Flow
-2.87 -4.30 0.56 0.10 0.50
Tangible Book Value Per Share
<0.01 0.36 23.58 62.62 137.31
Shareholders’ Equity Per Share
<0.01 0.36 23.58 62.62 137.31
Tax and Other Ratios
Effective Tax Rate
-0.18 0.12 0.18 0.17 0.13
Revenue Per Share
-0.02 0.25 0.00 0.00 0.00
Net Income Per Share
-4.05 -13.25 -32.23 -31.74 -34.86
Tax Burden
1.18 0.88 0.82 0.83 0.87
Interest Burden
0.52 1.00 0.94 1.00 0.91
Research & Development to Revenue
-106.04 45.61 0.00 0.00 0.00
SG&A to Revenue
-256.01 16.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
-8.07 3.51 0.00 0.00 0.00
Income Quality
0.88 0.71 0.98 0.98 0.94
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis